2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | |
公司类型 | 通用 | 通用 | 通用 | 通用 |
一、经营活动产生的现金流量: | ||||
销售商品、提供劳务收到的现金(元) | 20,153,006.18 | 45,009,407.78 | 21,913,773.18 | 43,370,718.29 |
收到的税费返还(元) | 1,008,461.38 | 4,076,411.97 | 2,647,750.43 | 2,769,625.81 |
收到其他与经营活动有关的现金(元) | 486,027.52 | 1,760,146.89 | 496,423.89 | 1,476,362.5 |
经营活动现金流入小计(元) | 21,647,495.08 | 50,845,966.64 | 25,057,947.5 | 47,616,706.6 |
购买商品、接受劳务支付的现金(元) | 3,054,390.09 | 7,109,088.84 | 2,394,993.52 | 8,880,854.72 |
支付给职工以及为职工支付的现金(元) | 11,035,353.55 | 20,939,342.8 | 10,203,051.17 | 20,128,873.96 |
支付的各项税费(元) | 1,942,127.34 | 4,133,588.56 | 1,636,027.91 | 5,242,848.44 |
支付其他与经营活动有关的现金(元) | 937,755.38 | 1,823,807.85 | 1,476,752.74 | 2,033,265.32 |
经营活动现金流出小计(元) | 16,969,626.36 | 34,005,828.05 | 15,710,825.34 | 36,285,842.44 |
经营活动产生的现金流量净额(元) | 4,677,868.72 | 16,840,138.59 | 9,347,122.16 | 11,330,864.16 |
二、投资活动产生的现金流量: | ||||
购建固定资产、无形资产和其他长期资产支付的现金(元) | 460,618 | 838,269 | 118,174 | 2,936,042.12 |
投资活动现金流出小计(元) | 460,618 | 838,269 | 118,174 | 2,936,042.12 |
投资活动产生的现金流量净额(元) | -460,618 | -838,269 | -118,174 | -2,936,042.12 |
三、筹资活动产生的现金流量: | ||||
取得借款收到的现金(元) | 2,500,000 | 6,010,000 | 4,000,000 | 12,000,000 |
筹资活动现金流入小计(元) | 2,500,000 | 6,010,000 | 4,000,000 | 12,000,000 |
偿还债务支付的现金(元) | 4,000,000 | 6,010,000 | 4,000,000 | 10,000,000 |
分配股利、利润或偿付利息支付的现金(元) | 2,177.77 | 7,340,238.9 | 0 | 16,500,240 |
支付其他与筹资活动有关的现金(元) | 1,002,316.79 | 2,169,746.27 | 1,002,316.79 | 2,111,988.35 |
筹资活动现金流出小计(元) | 5,004,494.56 | 15,519,985.17 | 5,002,316.79 | 28,612,228.35 |
筹资活动产生的现金流量净额(元) | -2,504,494.56 | -9,509,985.17 | -1,002,316.79 | -16,612,228.35 |
五、现金及现金等价物净增加额 | 1,712,756.16 | 6,491,884.42 | 8,226,631.37 | -8,217,406.31 |
加:期初现金及现金等价物余额(元) | 17,769,331.89 | 11,277,447.47 | 11,277,447.47 | 19,494,853.78 |
期末现金及现金等价物余额(元) | 19,482,088.05 | 17,769,331.89 | 19,504,078.84 | 11,277,447.47 |
补充资料 | ||||
净利润(元) | 2,488,920.79 | 7,883,132.09 | 4,325,489.8 | 10,508,053.92 |
固定资产和投资性房地产折旧(元) | 1,802,020.62 | 4,028,752.32 | 2,105,705.46 | 3,999,457.58 |
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) | 1,802,020.62 | 4,028,752.32 | 2,105,705.46 | 3,999,457.58 |
无形资产摊销(元) | 5,395.26 | 10,790.52 | 5,395.26 | 141,817.64 |
长期待摊费用摊销(元) | 52,354.14 | 626,993.11 | 313,585.56 | 588,134.04 |
财务费用(元) | 169,065.72 | 411,908.12 | 205,763.44 | 122,789.63 |
递延所得税(元) | -34,368.03 | -64,778.83 | -21,667.48 | 194,198.32 |
其中:递延所得税资产减少(元) | -34,368.03 | -26,253.74 | -1,819.76 | -54,444.49 |
递延所得税负债增加(元) | 0 | -38,525.09 | -19,847.72 | 248,642.81 |
存货的减少(元) | 1,198,933.47 | 833,579.09 | 674,259.5 | -813,610.98 |
经营性应收项目的减少(元) | -1,227,844.96 | 1,246,224.11 | 627,045.25 | -2,821,733.49 |
经营性应付项目的增加(元) | 188,993.6 | 1,990,285.95 | 1,317,701.42 | -910,541.57 |
经营活动产生的现金流量净额(元) | 4,677,868.72 | 16,840,138.59 | 9,347,122.16 | 11,330,864.16 |
现金的期末余额(元) | 19,482,088.05 | 17,769,331.89 | 19,504,078.84 | 11,277,447.47 |
减:现金的期初余额(元) | 17,769,331.89 | 11,277,447.47 | 11,277,447.47 | 19,494,853.78 |
现金及现金等价物的净增加额(元) | 1,712,756.16 | 6,491,884.42 | 8,226,631.37 | -8,217,406.31 |
公告日期 | 2024-08-16 | 2024-04-18 | 2023-08-18 | 2023-04-21 |